Elizabeth A. Johnson
- Research and Theory top 5%
- Oncology top 2%
- Lung Cancer Research Studies 8
- Pancreatic and Hepatic Oncology Research 5
-
- Lung Cancer Treatments and Mutations 8
- Toxicology top 2%
-
- Ethics in Clinical Research 8
-
- Pharmacogenetics and Drug Metabolism 7
- Drug-Induced Hepatotoxicity and Protection 6
-
- Patient Safety and Medication Errors 6
-
- Cancer Genomics and Diagnostics 5
- Co-authors
- James E. HerndonDorothy WatsonDavid W. JohnstoneDavid J. SugarbakerMichael A. MaddausGary M. StraussRichard L. SchilskyEverett E. Vokes
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of Clinical Oncology (9 papers)SHILAP Revista de lepidopterología (1 paper)
- Partner nations
- United StatesCanadaAustralia
In The Last Decade
Elizabeth A. Johnson
122 papers receiving 3.5k citations
Hit Papers
Peers
Comparison fields: 5 of 171
- Research and Theory 39
- Oncology 1.1k
- Pulmonary and Respiratory Medicine 1.3k
- Issues, ethics and legal aspects 33
- Toxicology 78
Countries citing papers authored by Elizabeth A. Johnson
This map shows the geographic impact of Elizabeth A. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth A. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth A. Johnson more than expected).
Fields of papers citing papers by Elizabeth A. Johnson
This network shows the impact of papers produced by Elizabeth A. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth A. Johnson. The network helps show where Elizabeth A. Johnson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Elizabeth A. Johnson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2023 | 1 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 13 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 2 | |
| 7 | 2022 | 6 | |
| 8 | 2018 | 17 | |
| 9 | 2016 | 115 | |
| 10 | Adjuvant Paclitaxel Plus Carboplatin Compared With Observation in Stage IB Non–Small-Cell Lung Cancer: CALGB 9633 With the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groupsbreakdown → | 2008 | 690 |
| 11 | 2007 | 42 | |
| 12 | 2005 | 36 | |
| 13 | 2004 | 6 | |
| 14 | 2004 | 45 | |
| 15 | 2003 | 13 | |
| 16 | 2002 | 7 | |
| 17 | Naming God She: The Theological Implications | 2000 | 0 |
| 18 | 1993 | 4 | |
| 19 | 1991 | 4 | |
| 20 | 1986 | 9 |
About Elizabeth A. Johnson
Elizabeth A. Johnson is a scholar working on Research and Theory, Issues, ethics and legal aspects and Health Informatics, having authored 130 papers that have together received 3.7k indexed citations. Recurring topics across this work include Ethics in Clinical Research (8 papers), Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Research Studies (8 papers), Pharmacogenetics and Drug Metabolism (7 papers), Drug-Induced Hepatotoxicity and Protection (6 papers), Patient Safety and Medication Errors (6 papers), Pancreatic and Hepatic Oncology Research (5 papers) and Cancer Genomics and Diagnostics (5 papers). The work is most often cited by research in Research and Theory (39 citations), Oncology (1.1k citations) and Pulmonary and Respiratory Medicine (1.3k citations). Elizabeth A. Johnson has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include James E. Herndon, Dorothy Watson, David W. Johnstone, David J. Sugarbaker, Michael A. Maddaus, Gary M. Strauss, Richard L. Schilsky, Everett E. Vokes, Mark R. Green and Heidi H. Gillenwater. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.